Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
Silke Gillessen, Gerhardt Attard, Tomasz M Beer, Himisha Beltran, Alberto Bossi, Rob Bristow, Brett Carver, Daniel Castellano, Byung Ha Chung, Noel Clarke, Gedske Daugaard, Ian D Davis, Johann de Bono, Rodolfo Borges dos Reis, Charles G Drake, Ros Eeles, Eleni Efstathiou, Christopher P Evans, Stefano Fanti, Felix Feng Show all
European Urology | ELSEVIER SCIENCE BV | Published : 2018
Awarded by NHMRC Practitioner Fellowship
We gratefully acknowledge all the participants in the Advanced Prostate Cancer Consensus Conference (APCCC) for their lively, stimulating discussions. We thank Thomas Cerny for his support and Stefanie Fischer for carefully reading and correcting the manuscript. We gratefully acknowledge the financial support of the following nonprofit organisations for the APCCC 2017: City and Canton of St. Gallen, Swiss Cancer Research Organisation, European School of Oncology, Swiss Cancer League, the Swiss Oncology Research Network SAKK, Swiss Cancer Foundation, Prostate Cancer Foundation. We would like to thank especially the Movember Foundation for generously supporting the APCCC 2017 conference.IDD is supported by an NHMRC Practitioner Fellowship (APP1102604). We would also like to thank the following supporters: Cantonal Hospital St. Gallen, EMPA Materials Science and Technology, Appenzeller Bier, Egger Gemusebau, Moving light and sound, Schwyter, Swiss, Wernli. We also acknowledge sponsorship from several different for-profit organisations including: Astellas, Bayer Health Care, Janssen, Sanofi Genzyme, Amgen, Bristol-Myers Squibb, Ferring, Roche, Tolmar, AstraZeneca, Clovis, Medivation, Orion, and Uro-Today (details on www.apccc.org). These for-profit organisations supported the conference financially but had no input in the scientific content or the final publication.